Isolated Cervical Dystonia: Management and Barriers to Care

被引:6
作者
Supnet, Melanie Leigh [1 ,2 ]
Acuna, Patrick [1 ,2 ]
Carr, Samuel J. [1 ,2 ]
Kristoper de Guzman, Jan [3 ]
Al Qahtani, Xena [1 ,2 ]
Multhaupt-Buell, Trisha [1 ,2 ]
Francoeur, Taylor [1 ,2 ]
Aldykiewicz, Gabrielle E. [1 ,2 ]
Alluri, Priyanka R. [1 ,2 ]
Campion, Lindsey [1 ,2 ]
Paul, Lisa [1 ,2 ]
Ozelius, Laurie [1 ,2 ]
Penney, Ellen B. [1 ,2 ]
Stephen, Christopher D. [1 ,2 ]
Dy-Hollins, Marisela [1 ,2 ]
Sharma, Nutan [1 ,2 ]
机构
[1] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA
[2] Harvard Med Sch, Boston, MA 02115 USA
[3] Jose R Reyes Mem Med Ctr, Dept Neurol, Manila, Philippines
来源
FRONTIERS IN NEUROLOGY | 2020年 / 11卷
关键词
cervical dystonia; movement disorders; treatment; barriers to care; clinical features; QUALITY-OF-LIFE; SPASMODIC TORTICOLLIS; FOCAL DYSTONIA; ONSET; LONG; BLEPHAROSPASM; EPIDEMIOLOGY; PREVALENCE; DISORDERS; SYMPTOMS;
D O I
10.3389/fneur.2020.591418
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Cervical dystonia (CD) is a rare disorder, and health care providers might be unfamiliar with its presentation, thus leading to delay in the initial diagnosis. The lack of awareness displays the need to highlight the clinical features and treatment in cervical dystonia. In our cohort, we have identified an earlier age of onset in men, despite an overall preponderance of affected women. Objective: We aim to identify the prevalence, age of onset, spread, and treatment modalities of CD in the population. We also highlight the barriers which patients encounter related to diagnosis, follow-up, and treatment. Methods: We reviewed 149 CD patients who attended specialized Dystonia Clinics over a 14-year period. Dystonia severity was rated using the Burke-Fahn-Marsden (BFM), Tsui, and Toronto Western Spasmodic Torticollis Rating Scales (TWSTRS). Mood and quality of life were assessed using Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI), and 36-Item Short Form Health Survey (SF-36). Results: CD patients were majority White (91.3%) and more commonly female (75.8%). Men had an earlier median age of onset, 40.5 years (p = 0.044). BAI revealed a mean score of 7.2 (+/- 6.4, n = 50) indicating minimal anxiety while BDI revealed a mean score of 7.30 (+/- 7.6, n = 50) indicating minimal depression. The only SF-36 subscales associated with CD severity were physical functioning (p = 0.040) pain (p = 0.008) and general health (p = 0.014). Conclusion: There appear to be gender differences in both the prevalence and age of onset of the disease. There was a 3-fold higher incidence in women than in men. CD patients of both sexes experience barriers to care, which can be reflected in their quality of life and time-to-diagnosis. In addition, males were less likely to experience an objective benefit with botulinum toxin treatment and more likely to discontinue care. Greater awareness of CD by health care providers is important to reduce the time-to-diagnosis.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] KinesioTaping after botulinum toxin type A for cervical dystonia in adult patients
    Dec-Cwiek, Malgorzata
    Porebska, Karolina
    Sawczynska, Katarzyna
    Kubala, Marcin
    Witkowska, Magdalena
    Zmijewska, Kinga
    Antczak, Jakub
    Pera, Joanna
    BRAIN AND BEHAVIOR, 2022, 12 (04):
  • [42] Nonmotor symptoms in primary adult-onset cervical dystonia and blepharospasm
    Yang, Jing
    Shao, Na
    Song, Wei
    Wei, Qianqian
    Ou, Ruwei
    Wu, Ying
    Shang, Hui-Fang
    BRAIN AND BEHAVIOR, 2017, 7 (02):
  • [43] Effects of an hidrotherapy program in the treatment of cervical dystonia. A pilot study
    Isabel Useros-Olmo, Ana
    Collado-Vazquez, Susana
    REVISTA DE NEUROLOGIA, 2010, 51 (11) : 669 - 676
  • [44] Mood symptoms in cervical dystonia: Relationship with motor symptoms and quality of life
    Rafee, Shameer
    Al-Hinai, Mahmood
    Douglas, Gillian
    Ndukwe, Ihedinachi
    Hutchinson, Michael
    CLINICAL PARKINSONISM & RELATED DISORDERS, 2023, 8
  • [45] Treatment satisfaction with botulinum toxin: a comparison between blepharospasm and cervical dystonia
    Leplow, Bernd
    Eggebrecht, Anna
    Pohl, Johannes
    PATIENT PREFERENCE AND ADHERENCE, 2017, 11 : 1555 - 1563
  • [46] Prevalence of cervical dystonia and spasmodic torticollis in the United States general population
    Jankovic, J.
    Tsui, J.
    Bergeron, C.
    PARKINSONISM & RELATED DISORDERS, 2007, 13 (07) : 411 - 416
  • [47] Patient perspectives on the therapeutic profile of botulinum neurotoxin type A in cervical dystonia
    Comella, Cynthia
    Ferreira, Joaquim J.
    Pain, Emilie
    Azoulai, Marion
    Om, Savary
    JOURNAL OF NEUROLOGY, 2021, 268 (03) : 903 - 912
  • [48] Randomised controlled trial of escitalopram for cervical dystonia with dystonic jerks/tremor
    Zoons, Evelien
    Booij, Jan
    Delnooz, Catherine C. S.
    Dijk, Joke M.
    Dreissen, Yasmine E. M.
    Koelman, Johannes H. T. M.
    van der Salm, Sandra M. A.
    Skorvanek, Matej
    Smit, Marenka
    Aramideh, Majid
    Bienfait, Henriette
    Boon, Agnita J. W.
    Brans, Jeroen W. M.
    Hoogerwaard, Edo
    Hovestadt, Ad
    Kamphuis, Daan J.
    Munts, Alexander G.
    Speelman, Johannes D.
    Tijssen, Marina A. J.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 (06) : 579 - 585
  • [49] Language in people with cervical dystonia: Evidence of grammatical and specific semantic deficits
    White, Jessica
    Mahady, Laura
    Rafee, Shameer
    Hutchinson, Michael
    O'Riordan, Sean
    O'Keeffe, Fiadhnait
    Gough, Patricia
    JOURNAL OF NEUROLINGUISTICS, 2025, 73
  • [50] The Impact of the Course of Disease before Botulinum Toxin Therapy on the Course of Treatment and Long-Term Outcome in Cervical Dystonia
    Hefter, Harald
    Schomaecker, Isabelle
    Schomaecker, Max
    Rosenthal, Dietmar
    Samadzadeh, Sara
    TOXINS, 2021, 13 (07)